Company intelligence / Profile preview

TopiVert Pharma Limited

London, England, United Kingdomuk.linkedin.com ↗

Ownership: Private
Development stage: Phase 2

Overview

TopiVert developed locally acting small molecule kinase inhibitors for chronic inflammatory diseases of the GI tract and eye. Lead program TOP1288 showed strong safety and pharmacodynamic data in a Phase I study for ulcerative colitis. Ophthalmology candidate TOP1630 demonstrated proof-of-concept efficacy in dry eye syndrome with positive results from a US-based Phase I/IIa trial. A multicenter randomized placebo-controlled phase IIb/III trial was underway for DED as of the last reports. The company’s NSKI technology aimed to provide potent anti-inflammatory effects with minimal systemic exposure.

Therapeutic areas: GastroenterologyOphthalmology
Modalities: Small molecules (specifically Narrow Spectrum Kinase Inhibitors, NSKIs)
Industry: Biotech

Drug pipeline

3 assets

TOP1630

2 more assets in the full pipeline.

Request access →

Partnerships

No major pharma partnerships disclosed; investors include Johnson & Johnson Innovation – JJDC, Inc., SV Health Investors, Touchstone Innovations, NeoMed.

Beyond the preview

Go deeper on TopiVert Pharma Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TopiVert Pharma Limited.

Explore the full profile